Breaking News: Trump Persuades Pharmaceutical Companies to Sell Obesity Drugs at Discounted Prices
On November 6, 2025, in Washington, U.S. President Donald Trump, along with U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., made statements regarding drug prices in the White House Oval Office:
The world's two largest pharmaceutical companies, Eli Lilly and Novo Nordisk, have agreed to sell their most effective obesity drugs, GLP-1, at significant discounts.
Robert F. Kennedy Jr. emphasized:
Obesity is a disease of poverty, but although people with the lowest incomes often have a higher likelihood of chronic illness, this is not always the case. It does not only affect low-income Americans.
Original article: www.toutiao.com/article/1848092889708551/
Statement: This article represents the views of the author.